Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
690K
-
Shares change
-
+21.1K
-
Total reported value, excl. options
-
$1.69M
-
Value change
-
+$51.8K
-
Number of buys
-
6
-
Number of sells
-
-5
-
Price
-
$2.46
Significant Holders of Lexaria Bioscience Corp. - COM NEW (LEXX) as of Q4 2022
13 filings reported holding LEXX - Lexaria Bioscience Corp. - COM NEW as of Q4 2022.
Lexaria Bioscience Corp. - COM NEW (LEXX) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 690K shares
.
Largest 10 shareholders include Invenomic Capital Management LP (473K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (66.1K shares), GEODE CAPITAL MANAGEMENT, LLC (48.8K shares), VANGUARD GROUP INC (33.3K shares), CITADEL ADVISORS LLC (18.7K shares), DIMENSIONAL FUND ADVISORS LP (15.3K shares), Centiva Capital, LP (13.1K shares), RENAISSANCE TECHNOLOGIES LLC (11.5K shares), UBS Group AG (5.6K shares), and 1832 Asset Management L.P. (2.69K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.